A detailed history of Lpl Financial LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Lpl Financial LLC holds 584,773 shares of AZN stock, worth $38.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
584,773
Previous 539,191 8.45%
Holding current value
$38.8 Million
Previous $42.1 Million 8.36%
% of portfolio
0.02%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$76.67 - $87.62 $3.49 Million - $3.99 Million
45,582 Added 8.45%
584,773 $45.6 Million
Q2 2024

Aug 07, 2024

BUY
$66.81 - $80.83 $3.63 Million - $4.39 Million
54,345 Added 11.21%
539,191 $42.1 Million
Q1 2024

May 10, 2024

BUY
$61.03 - $69.57 $4.88 Million - $5.56 Million
79,972 Added 19.75%
484,846 $32.8 Million
Q4 2023

Feb 14, 2024

BUY
$61.89 - $69.28 $4.73 Million - $5.29 Million
76,416 Added 23.27%
404,874 $27.3 Million
Q3 2023

Nov 13, 2023

BUY
$64.85 - $71.7 $491,692 - $543,629
7,582 Added 2.36%
328,458 $22.2 Million
Q2 2023

Jul 31, 2023

BUY
$69.91 - $75.81 $4.47 Million - $4.84 Million
63,872 Added 24.85%
320,876 $23 Million
Q1 2023

May 10, 2023

BUY
$63.15 - $71.6 $301,162 - $341,460
4,769 Added 1.89%
257,004 $17.8 Million
Q4 2022

Feb 07, 2023

BUY
$54.21 - $70.44 $821,498 - $1.07 Million
15,154 Added 6.39%
252,235 $17.1 Million
Q3 2022

Nov 14, 2022

BUY
$53.02 - $135.75 $1.69 Million - $4.33 Million
31,885 Added 15.54%
237,081 $13 Million
Q2 2022

Aug 12, 2022

BUY
$59.26 - $71.14 $212,624 - $255,250
3,588 Added 1.78%
205,196 $13.6 Million
Q1 2022

May 16, 2022

SELL
$55.72 - $67.12 $1.79 Million - $2.15 Million
-32,101 Reduced 13.74%
201,608 $13.4 Million
Q4 2021

Feb 14, 2022

BUY
$54.02 - $63.83 $586,495 - $693,002
10,857 Added 4.87%
233,709 $13.6 Million
Q3 2021

Nov 15, 2021

BUY
$55.56 - $60.79 $1.41 Million - $1.54 Million
25,316 Added 12.82%
222,852 $13.4 Million
Q2 2021

Aug 13, 2021

SELL
$48.42 - $60.18 $804,740 - $1 Million
-16,620 Reduced 7.76%
197,536 $11.8 Million
Q1 2021

May 14, 2021

SELL
$47.16 - $54.44 $358,085 - $413,362
-7,593 Reduced 3.42%
214,156 $10.6 Million
Q4 2020

Feb 12, 2021

BUY
$48.52 - $58.02 $1.41 Million - $1.69 Million
29,127 Added 15.12%
221,749 $11.1 Million
Q3 2020

Nov 09, 2020

BUY
$53.07 - $61.1 $491,693 - $566,091
9,265 Added 5.05%
192,622 $10.6 Million
Q2 2020

Aug 13, 2020

BUY
$43.1 - $55.31 $1.78 Million - $2.29 Million
41,342 Added 29.11%
183,357 $9.7 Million
Q1 2020

May 14, 2020

BUY
$37.79 - $51.33 $179,804 - $244,228
4,758 Added 3.47%
142,015 $6.34 Million
Q4 2019

Feb 14, 2020

BUY
$42.46 - $50.46 $431,223 - $512,471
10,156 Added 7.99%
137,257 $6.84 Million
Q3 2019

Nov 13, 2019

BUY
$40.12 - $45.47 $568,901 - $644,764
14,180 Added 12.56%
127,101 $5.67 Million
Q2 2019

Aug 09, 2019

BUY
$37.28 - $41.68 $212,831 - $237,951
5,709 Added 5.32%
112,921 $4.66 Million
Q1 2019

May 08, 2019

SELL
$35.49 - $43.02 $4.19 Million - $5.07 Million
-117,967 Reduced 52.39%
107,212 $4.34 Million
Q4 2018

Feb 07, 2019

SELL
$36.86 - $41.49 $1.16 Million - $1.31 Million
-31,519 Reduced 12.28%
225,179 $8.55 Million
Q3 2018

Nov 14, 2018

SELL
$34.76 - $39.72 $3 Million - $3.43 Million
-86,399 Reduced 25.18%
256,698 $10.2 Million
Q2 2018

Aug 14, 2018

SELL
$34.55 - $37.05 $2.54 Million - $2.72 Million
-73,528 Reduced 17.65%
343,097 $12 Million
Q1 2018

May 15, 2018

BUY
$32.97 - $36.63 $7.83 Million - $8.7 Million
237,491 Added 132.58%
416,625 $14.6 Million
Q4 2017

Feb 14, 2018

SELL
$32.09 - $34.78 $2,952 - $3,199
-92 Reduced 0.05%
179,134 $6.22 Million
Q3 2017

Nov 14, 2017

SELL
$28.96 - $34.0 $329,593 - $386,954
-11,381 Reduced 5.97%
179,226 $6.07 Million
Q2 2017

Aug 14, 2017

BUY
N/A
190,607
190,607 $6.5 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $206B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.